Allergan, the US-based pharmaceutical company, will be expanding its Botox-manufacturing empire into Ireland. The renowned company will be investing $350 million in its facility in western Ireland, where it will create 200 new jobs for the local economy.

Botox is already a billion-dollar product. With its approval as a treatment for migraines and overactive bladders, its profit is expected to rise in the upcoming year.

The new jobs will be good for the domestic Irish economy, which has struggled against the recession.